Neoadjuvant chemotherapy for hypervascular malignant brain tumors of childhood

Pediatr Neurosurg. 1997 Dec;27(6):296-303. doi: 10.1159/000121274.

Abstract

Some large hypervascular brain tumors pose an exceptional challenge to surgical resection, particularly in young children with small blood volumes. To limit blood loss during resection of hypervascular tumors, the authors used upfront chemotherapy as the primary treatment modality in 2 young children. This produced a dramatic reduction in tumor size and vascularity and greatly facilitated definitive surgical removal.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Brain Neoplasms / blood supply
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / surgery
  • Carcinoma / blood supply
  • Carcinoma / drug therapy*
  • Carcinoma / surgery
  • Chemotherapy, Adjuvant
  • Child, Preschool
  • Choroid Plexus Neoplasms / blood supply
  • Choroid Plexus Neoplasms / drug therapy*
  • Choroid Plexus Neoplasms / surgery
  • Combined Modality Therapy
  • Diagnostic Imaging
  • Follow-Up Studies
  • Humans
  • Infant
  • Male
  • Neoplasm, Residual / blood supply
  • Neoplasm, Residual / drug therapy
  • Neoplasm, Residual / surgery
  • Neovascularization, Pathologic / diagnosis
  • Neovascularization, Pathologic / drug therapy*
  • Neovascularization, Pathologic / surgery
  • Neuroectodermal Tumors, Primitive / blood supply
  • Neuroectodermal Tumors, Primitive / drug therapy*
  • Neuroectodermal Tumors, Primitive / surgery
  • Reoperation